Total: £ 56.28
Published Date: 2022-05-23 | Pages: 122 | Tables: 150 | Medical Care
Market Analysis and Insights: Global and United States Pain Relievers Market
This report focuses on global and United States Pain Relievers market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Pain Relievers market size is estimated to be worth US$ 4840.7 million in 2022 and is forecast to a readjusted size of US$ 6026.7 million by 2028 with a CAGR of 3.7% during the review period. Fully considering the economic change by this health crisis, by Type, Nonsteroidal Anti-inflammatory Drugs accounting for % of the Pain Relievers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Headache was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Pain Relievers market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Pain Relievers Scope and Market Size
Pain Relievers market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pain Relievers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Pain Relievers market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Nonsteroidal Anti-inflammatory Drugs
Central Analgesics
Segment by Application
Headache
Toothache
Arthralgia
Menstrual Pain
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Reckitt Benckiser Group Plc
Novartis AG
Topical BioMedics
AdvaCare Pharma
Sun Pharmaceutical
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Pain Relievers Revenue in Pain Relievers Business (2017-2022) & (US$ Million) Introduction
1.2 Global Pain Relievers Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pain Relievers Market Size for the Year 2017-2028
1.2.2 Global Pain Relievers Market Size for the Year 2017-2028
1.3 Pain Relievers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Pain Relievers in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Pain Relievers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Pain Relievers Market Dynamics
1.4.1 Pain Relievers Industry Trends
1.4.2 Pain Relievers Market Drivers
1.4.3 Pain Relievers Market Challenges
1.4.4 Pain Relievers Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Pain Relievers by Type
2.1 Pain Relievers Market Segment by Type
2.1.1 Nonsteroidal Anti-inflammatory Drugs
2.1.2 Central Analgesics
2.2 Global Pain Relievers Market Size by Type (2017, 2022 & 2028)
2.3 Global Pain Relievers Market Size by Type (2017-2028)
2.4 United States Pain Relievers Market Size by Type (2017, 2022 & 2028)
2.5 United States Pain Relievers Market Size by Type (2017-2028)
3 Pain Relievers by Application
3.1 Pain Relievers Market Segment by Application
3.1.1 Headache
3.1.2 Toothache
3.1.3 Arthralgia
3.1.4 Menstrual Pain
3.1.5 Other
3.2 Global Pain Relievers Market Size by Application (2017, 2022 & 2028)
3.3 Global Pain Relievers Market Size by Application (2017-2028)
3.4 United States Pain Relievers Market Size by Application (2017, 2022 & 2028)
3.5 United States Pain Relievers Market Size by Application (2017-2028)
4 Global Pain Relievers Competitor Landscape by Company
4.1 Global Pain Relievers Market Size by Company
4.1.1 Top Global Pain Relievers Companies Ranked by Revenue (2021)
4.1.2 Global Pain Relievers Revenue by Player (2017-2022)
4.2 Global Pain Relievers Concentration Ratio (CR)
4.2.1 Pain Relievers Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pain Relievers in 2021
4.2.3 Global Pain Relievers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pain Relievers Headquarters, Revenue in Pain Relievers Business (2017-2022) & (US$ Million) Type
4.3.1 Global Pain Relievers Headquarters and Area Served
4.3.2 Global Pain Relievers Companies Revenue in Pain Relievers Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Pain Relievers Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Pain Relievers Market Size by Company
4.5.1 Top Pain Relievers Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pain Relievers Revenue by Players (2020, 2021 & 2022)
5 Global Pain Relievers Market Size by Region
5.1 Global Pain Relievers Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pain Relievers Market Size by Region (2017-2028)
5.2.1 Global Pain Relievers Market Size by Region: 2017-2022
5.2.2 Global Pain Relievers Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pain Relievers Market Size YoY Growth 2017-2028
6.1.2 North America Pain Relievers Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pain Relievers Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pain Relievers Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pain Relievers Market Size YoY Growth 2017-2028
6.3.2 Europe Pain Relievers Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pain Relievers Market Size YoY Growth 2017-2028
6.4.2 Latin America Pain Relievers Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pain Relievers Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pain Relievers Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pain Relievers Introduction
7.1.4 Pfizer Revenue in Pain Relievers Business (2017-2022)
7.1.5 Pfizer Recent Development
7.2 GSK
7.2.1 GSK Company Details
7.2.2 GSK Business Overview
7.2.3 GSK Pain Relievers Introduction
7.2.4 GSK Revenue in Pain Relievers Business (2017-2022)
7.2.5 GSK Recent Development
7.3 Grunenthal
7.3.1 Grunenthal Company Details
7.3.2 Grunenthal Business Overview
7.3.3 Grunenthal Pain Relievers Introduction
7.3.4 Grunenthal Revenue in Pain Relievers Business (2017-2022)
7.3.5 Grunenthal Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Pain Relievers Introduction
7.4.4 Bayer Revenue in Pain Relievers Business (2017-2022)
7.4.5 Bayer Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Details
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Pain Relievers Introduction
7.5.4 Sanofi Revenue in Pain Relievers Business (2017-2022)
7.5.5 Sanofi Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Company Details
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Pain Relievers Introduction
7.6.4 Eli Lilly Revenue in Pain Relievers Business (2017-2022)
7.6.5 Eli Lilly Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Company Details
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Pain Relievers Introduction
7.7.4 AstraZeneca Revenue in Pain Relievers Business (2017-2022)
7.7.5 AstraZeneca Recent Development
7.8 Endo
7.8.1 Endo Company Details
7.8.2 Endo Business Overview
7.8.3 Endo Pain Relievers Introduction
7.8.4 Endo Revenue in Pain Relievers Business (2017-2022)
7.8.5 Endo Recent Development
7.9 Merck
7.9.1 Merck Company Details
7.9.2 Merck Business Overview
7.9.3 Merck Pain Relievers Introduction
7.9.4 Merck Revenue in Pain Relievers Business (2017-2022)
7.9.5 Merck Recent Development
7.10 Depomed
7.10.1 Depomed Company Details
7.10.2 Depomed Business Overview
7.10.3 Depomed Pain Relievers Introduction
7.10.4 Depomed Revenue in Pain Relievers Business (2017-2022)
7.10.5 Depomed Recent Development
7.11 Yunnan Baiyao
7.11.1 Yunnan Baiyao Company Details
7.11.2 Yunnan Baiyao Business Overview
7.11.3 Yunnan Baiyao Pain Relievers Introduction
7.11.4 Yunnan Baiyao Revenue in Pain Relievers Business (2017-2022)
7.11.5 Yunnan Baiyao Recent Development
7.12 Teva
7.12.1 Teva Company Details
7.12.2 Teva Business Overview
7.12.3 Teva Pain Relievers Introduction
7.12.4 Teva Revenue in Pain Relievers Business (2017-2022)
7.12.5 Teva Recent Development
7.13 J&J
7.13.1 J&J Company Details
7.13.2 J&J Business Overview
7.13.3 J&J Pain Relievers Introduction
7.13.4 J&J Revenue in Pain Relievers Business (2017-2022)
7.13.5 J&J Recent Development
7.14 Allergan
7.14.1 Allergan Company Details
7.14.2 Allergan Business Overview
7.14.3 Allergan Pain Relievers Introduction
7.14.4 Allergan Revenue in Pain Relievers Business (2017-2022)
7.14.5 Allergan Recent Development
7.15 Purdue
7.15.1 Purdue Company Details
7.15.2 Purdue Business Overview
7.15.3 Purdue Pain Relievers Introduction
7.15.4 Purdue Revenue in Pain Relievers Business (2017-2022)
7.15.5 Purdue Recent Development
7.16 Reckitt Benckiser Group Plc
7.16.1 Reckitt Benckiser Group Plc Company Details
7.16.2 Reckitt Benckiser Group Plc Business Overview
7.16.3 Reckitt Benckiser Group Plc Pain Relievers Introduction
7.16.4 Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2017-2022)
7.16.5 Reckitt Benckiser Group Plc Recent Development
7.17 Novartis AG
7.17.1 Novartis AG Company Details
7.17.2 Novartis AG Business Overview
7.17.3 Novartis AG Pain Relievers Introduction
7.17.4 Novartis AG Revenue in Pain Relievers Business (2017-2022)
7.17.5 Novartis AG Recent Development
7.18 Topical BioMedics
7.18.1 Topical BioMedics Company Details
7.18.2 Topical BioMedics Business Overview
7.18.3 Topical BioMedics Pain Relievers Introduction
7.18.4 Topical BioMedics Revenue in Pain Relievers Business (2017-2022)
7.18.5 Topical BioMedics Recent Development
7.19 AdvaCare Pharma
7.19.1 AdvaCare Pharma Company Details
7.19.2 AdvaCare Pharma Business Overview
7.19.3 AdvaCare Pharma Pain Relievers Introduction
7.19.4 AdvaCare Pharma Revenue in Pain Relievers Business (2017-2022)
7.19.5 AdvaCare Pharma Recent Development
7.20 Sun Pharmaceutical
7.20.1 Sun Pharmaceutical Company Details
7.20.2 Sun Pharmaceutical Business Overview
7.20.3 Sun Pharmaceutical Pain Relievers Introduction
7.20.4 Sun Pharmaceutical Revenue in Pain Relievers Business (2017-2022)
7.20.5 Sun Pharmaceutical Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Pain Relievers Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Pain Relievers Market Trends
Table 3. Pain Relievers Market Drivers
Table 4. Pain Relievers Market Challenges
Table 5. Pain Relievers Market Restraints
Table 6. Global Pain Relievers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pain Relievers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pain Relievers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pain Relievers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pain Relievers Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Pain Relievers Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Pain Relievers Revenue Share by Player, 2017-2022
Table 13. Global Pain Relievers Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pain Relievers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Relievers as of 2021)
Table 15. Top Players of Pain Relievers in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Pain Relievers Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Pain Relievers Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Pain Relievers Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Pain Relievers Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Pain Relievers Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Pain Relievers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Pain Relievers Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Pain Relievers Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Pain Relievers Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Pain Relievers Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Pain Relievers Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Pain Relievers Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Pain Relievers Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer Pain Relievers Product
Table 33. Pfizer Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. GSK Company Details
Table 36. GSK Business Overview
Table 37. GSK Pain Relievers Product
Table 38. GSK Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 39. GSK Recent Development
Table 40. Grunenthal Company Details
Table 41. Grunenthal Business Overview
Table 42. Grunenthal Pain Relievers Product
Table 43. Grunenthal Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 44. Grunenthal Recent Development
Table 45. Bayer Company Details
Table 46. Bayer Business Overview
Table 47. Bayer Pain Relievers Product
Table 48. Bayer Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 49. Bayer Recent Development
Table 50. Sanofi Company Details
Table 51. Sanofi Business Overview
Table 52. Sanofi Pain Relievers Product
Table 53. Sanofi Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 54. Sanofi Recent Development
Table 55. Eli Lilly Company Details
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Pain Relievers Product
Table 58. Eli Lilly Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly Recent Development
Table 60. AstraZeneca Company Details
Table 61. AstraZeneca Business Overview
Table 62. AstraZeneca Pain Relievers Product
Table 63. AstraZeneca Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 64. AstraZeneca Recent Development
Table 65. Endo Company Details
Table 66. Endo Business Overview
Table 67. Endo Pain Relievers Product
Table 68. Endo Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 69. Endo Recent Development
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Pain Relievers Product
Table 73. Merck Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 74. Merck Recent Development
Table 75. Depomed Company Details
Table 76. Depomed Business Overview
Table 77. Depomed Pain Relievers Product
Table 78. Depomed Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 79. Depomed Recent Development
Table 80. Yunnan Baiyao Company Details
Table 81. Yunnan Baiyao Business Overview
Table 82. Yunnan Baiyao Pain Relievers Product
Table 83. Yunnan Baiyao Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 84. Yunnan Baiyao Recent Development
Table 85. Teva Company Details
Table 86. Teva Business Overview
Table 87. Teva Pain Relievers Product
Table 88. Teva Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 89. Teva Recent Development
Table 90. J&J Company Details
Table 91. J&J Business Overview
Table 92. J&J Pain Relievers Product
Table 93. J&J Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 94. J&J Recent Development
Table 95. Allergan Company Details
Table 96. Allergan Business Overview
Table 97. Allergan Pain Relievers Product
Table 98. Allergan Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 99. Allergan Recent Development
Table 100. Purdue Company Details
Table 101. Purdue Business Overview
Table 102. Purdue Pain Relievers Product
Table 103. Purdue Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 104. Purdue Recent Development
Table 105. Reckitt Benckiser Group Plc Company Details
Table 106. Reckitt Benckiser Group Plc Business Overview
Table 107. Reckitt Benckiser Group Plc Pain Relievers Product
Table 108. Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 109. Reckitt Benckiser Group Plc Recent Development
Table 110. Novartis AG Company Details
Table 111. Novartis AG Business Overview
Table 112. Novartis AG Pain Relievers Product
Table 113. Novartis AG Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 114. Novartis AG Recent Development
Table 115. Topical BioMedics Company Details
Table 116. Topical BioMedics Business Overview
Table 117. Topical BioMedics Pain Relievers Product
Table 118. Topical BioMedics Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 119. Topical BioMedics Recent Development
Table 120. AdvaCare Pharma Company Details
Table 121. AdvaCare Pharma Business Overview
Table 122. AdvaCare Pharma Pain Relievers Product
Table 123. AdvaCare Pharma Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 124. AdvaCare Pharma Recent Development
Table 125. Sun Pharmaceutical Company Details
Table 126. Sun Pharmaceutical Business Overview
Table 127. Sun Pharmaceutical Pain Relievers Product
Table 128. Sun Pharmaceutical Revenue in Pain Relievers Business (2017-2022) & (US$ Million)
Table 129. Sun Pharmaceutical Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Pain Relievers Product Picture
Figure 2. Global Pain Relievers Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pain Relievers Market Size 2017-2028 (US$ Million)
Figure 4. United States Pain Relievers Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Pain Relievers Market Size 2017-2028 (US$ Million)
Figure 6. United States Pain Relievers Market Share in Global 2017-2028
Figure 7. Pain Relievers Report Years Considered
Figure 8. Product Picture of Nonsteroidal Anti-inflammatory Drugs
Figure 9. Product Picture of Central Analgesics
Figure 10. Global Pain Relievers Market Share by Type in 2022 & 2028
Figure 11. Global Pain Relievers Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Pain Relievers Market Share by Type (2017-2028)
Figure 13. United States Pain Relievers Market Share by Type in 2022 & 2028
Figure 14. United States Pain Relievers Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Pain Relievers Market Share by Type (2017-2028)
Figure 16. Product Picture of Headache
Figure 17. Product Picture of Toothache
Figure 18. Product Picture of Arthralgia
Figure 19. Product Picture of Menstrual Pain
Figure 20. Product Picture of Other
Figure 21. Global Pain Relievers Market Share by Application in 2022 & 2028
Figure 22. Global Pain Relievers Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Pain Relievers Market Share by Application (2017-2028)
Figure 24. United States Pain Relievers Market Share by Application in 2022 & 2028
Figure 25. United States Pain Relievers Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Pain Relievers Market Share by Application (2017-2028)
Figure 27. North America Pain Relievers Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Pain Relievers Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Pain Relievers Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Pain Relievers Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Pain Relievers Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. UAE Pain Relievers Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 56. GSK Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 57. Grunenthal Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 58. Bayer Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 59. Sanofi Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 60. Eli Lilly Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 62. Endo Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 63. Merck Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 64. Depomed Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 65. Yunnan Baiyao Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 66. Teva Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 67. J&J Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 68. Allergan Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 69. Purdue Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 70. Reckitt Benckiser Group Plc Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 71. Novartis AG Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 72. Topical BioMedics Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 73. AdvaCare Pharma Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 74. Sun Pharmaceutical Revenue Growth Rate in Pain Relievers Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed